Dr. Autumn Mcree, MD

NPI: 1609923499
Total Payments
$29,772
2021 Payments
$1,350
Companies
5
Transactions
41
Medicare Patients
426
Medicare Billing
$64,307

Payment Breakdown by Category

Consulting$22,050 (74.1%)
Travel$3,622 (12.2%)
Other$2,224 (7.5%)
Food & Beverage$1,091 (3.7%)
Research$785.42 (2.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $22,050 6 74.1%
Travel and Lodging $3,622 13 12.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,224 2 7.5%
Food and Beverage $1,091 19 3.7%
Unspecified $785.42 1 2.6%

Payments by Type

General
$28,987
40 transactions
Research
$785.42
1 transactions

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $26,540 34 $0 (2021)
F. Hoffmann-La Roche AG $2,224 2 $0 (2018)
NOVARTIS PHARMACEUTICALS CORPORATION $785.42 1 $0 (2017)
Genentech, Inc. $158.54 3 $0 (2018)
Genentech USA, Inc. $64.17 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2021 $1,350 1 Merck Sharp & Dohme Corporation ($1,350)
2019 $6,199 8 Merck Sharp & Dohme Corporation ($6,199)
2018 $8,284 13 Merck Sharp & Dohme Corporation ($5,901)
2017 $13,940 19 Merck Sharp & Dohme Corporation ($13,091)

All Payment Transactions

41 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
07/01/2021 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $1,350.00 General
03/13/2019 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $4,950.00 General
03/13/2019 Merck Sharp & Dohme Corporation Travel and Lodging Cash or cash equivalent $150.00 General
03/01/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $125.00 General
03/01/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $50.00 General
03/01/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $50.00 General
03/01/2019 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $35.00 General
02/28/2019 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $573.34 General
02/28/2019 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $265.37 General
06/03/2018 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $118.40 General
04/30/2018 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $4,950.00 General
04/30/2018 Merck Sharp & Dohme Corporation Travel and Lodging Cash or cash equivalent $150.00 General
04/20/2018 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $49.99 General
04/20/2018 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $39.97 General
04/20/2018 Merck Sharp & Dohme Corporation Food and Beverage In-kind items and services $34.99 General
04/19/2018 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $377.96 General
04/19/2018 Merck Sharp & Dohme Corporation Travel and Lodging In-kind items and services $179.67 General
03/31/2018 F. Hoffmann-La Roche AG TECENTRIQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $1,454.07 General
Category: BioOncology
03/31/2018 F. Hoffmann-La Roche AG TECENTRIQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $769.97 General
Category: BioOncology
01/21/2018 Genentech, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $8.98 General
Category: BioOncology
01/15/2018 Genentech, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $81.40 General
Category: BioOncology
01/15/2018 Genentech, Inc. TECENTRIQ (Biological) Food and Beverage In-kind items and services $68.16 General
Category: BioOncology
12/18/2017 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $900.00 General
11/01/2017 NOVARTIS PHARMACEUTICALS CORPORATION TAFINLAR (Drug) In-kind items and services $785.42 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: ONCOLOGY
08/02/2017 Merck Sharp & Dohme Corporation Consulting Fee Cash or cash equivalent $4,950.00 General

Research Studies & Clinical Trials

Study Name Company Amount Records
RESEARCH RELATED PUBLICATION SUPPORT NOVARTIS PHARMACEUTICALS CORPORATION $785.42 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 4 190 349 $134,533 $38,031
2020 9 236 347 $111,417 $26,276
Total Patients
426
Total Services
696
Medicare Billing
$64,307
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 93 241 $89,041 $26,999 30.3%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 41 41 $24,826 $5,983 24.1%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 45 56 $15,129 $3,866 25.6%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 11 11 $5,537 $1,183 21.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 73 142 $36,983 $7,992 21.6%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 39 61 $21,593 $5,388 25.0%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 30 30 $17,565 $3,766 21.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 17 34 $10,470 $2,816 26.9%
99204 New patient office or other outpatient visit, typically 45 minutes Facility 2020 21 21 $10,183 $2,143 21.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 12 12 $7,164 $1,923 26.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 14 14 $4,430 $1,187 26.8%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2020 18 20 $2,200 $815.40 37.1%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2020 12 13 $829.00 $245.87 29.7%

About Dr. Autumn Mcree, MD

Dr. Autumn Mcree, MD is a Hematology & Oncology healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609923499.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Autumn Mcree, MD has received a total of $29,772 in payments from pharmaceutical and medical device companies, with $1,350 received in 2021. These payments were reported across 41 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($22,050).

As a Medicare-enrolled provider, Mcree has provided services to 426 Medicare beneficiaries, totaling 696 services with total Medicare billing of $64,307. Data is available for 2 years (2020–2021), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Hematology & Oncology
  • Location Chapel Hill, NC
  • Active Since 01/04/2007
  • Last Updated 06/08/2012
  • Taxonomy Code 207RH0003X
  • Entity Type Individual
  • NPI Number 1609923499

Products in Payments

  • TECENTRIQ (Biological) $2,383
  • TAFINLAR (Drug) $785.42
  • Avastin (Biological) $64.17

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology & Oncology Doctors in Chapel Hill